Literature DB >> 8274470

Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression.

R L Reddick1, S H Zhang, N Maeda.   

Abstract

Apolipoprotein E-deficient mice have spontaneous elevations of total plasma cholesterol and triglycerides and reduced high-density lipoprotein. The mice develop arterial lesions in a time-dependent manner. Lesional distribution was centered in the aortic sinus in young mice, and the lesions were widely distributed throughout the arterial tree in mice at 8 to 9 months of age. In young mice, subendothelial foam cell deposits were present in the aortic sinus adjacent to valve-attachment sites. By 5 months of age, foam cell deposits, free cholesterol, and admixed smooth muscle cells composed the developing atherosclerotic lesions. After 8 to 9 months of age, the arterial lesions showed increased complexity, and fibrous cap lesions were present. Transmission electron microscopy showed foam cells, smooth muscle cells (both contractile and synthetic varieties), cellular debris, and acicular cholesterol deposits within the plaques. By scanning electron microscopy, subendothelial collections of foam cells were present within the aortic sinus and ascending aorta. The results show that the complexity of the atherosclerotic lesions that develop in these apo E deficient-mice are similar to those described in other species and therefore represent an important model for studies of genetic and environmental influences on the atherosclerotic process.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8274470     DOI: 10.1161/01.atv.14.1.141

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  171 in total

1.  Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice.

Authors:  J H Qiao; J Tripathi; N K Mishra; Y Cai; S Tripathi; X P Wang; S Imes; M C Fishbein; S K Clinton; P Libby; A J Lusis; T B Rajavashisth
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.

Authors:  W Palinski; S Hörkkö; E Miller; U P Steinbrecher; H C Powell; L K Curtiss; J L Witztum
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  Addition of aspirin to a fish oil-rich diet decreases inflammation and atherosclerosis in ApoE-null mice.

Authors:  Alexander V Sorokin; Zhi-Hong Yang; Boris L Vaisman; Seth Thacker; Zu-Xi Yu; Maureen Sampson; Charles N Serhan; Alan T Remaley
Journal:  J Nutr Biochem       Date:  2016-06-19       Impact factor: 6.048

4.  Mutant mice derived by ICSI of evaporatively dried spermatozoa exhibit expected phenotype.

Authors:  Ming-Wen Li; Brian Baridon; Amanda Trainor; Esi Djan; Amanda Koehne; Stephen M Griffey; John D Biggers; Mehmet Toner; K C Kent Lloyd
Journal:  Reproduction       Date:  2012-01-24       Impact factor: 3.906

5.  apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.

Authors:  Panagiotis Fotakis; Alexander Vezeridis; Ioannis Dafnis; Angeliki Chroni; Dimitris Kardassis; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2014-04-28       Impact factor: 5.922

6.  Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.

Authors:  S Bellosta; R W Mahley; D A Sanan; J Murata; D L Newland; J M Taylor; R E Pitas
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

7.  Allele-dependent thermodynamic and structural perturbations in ApoE variants associated with the correction of dyslipidemia and formation of spherical ApoE-containing HDL particles.

Authors:  Dimitra Georgiadou; Angeliki Chroni; Konstantinos Drosatos; Kyriakos E Kypreos; Vassilis I Zannis; Efstratios Stratikos
Journal:  Atherosclerosis       Date:  2012-11-23       Impact factor: 5.162

8.  Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression.

Authors:  Cecilia M Devlin; Andrew R Leventhal; George Kuriakose; Edward H Schuchman; Kevin Jon Williams; Ira Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-31       Impact factor: 8.311

9.  Hepatic overexpression of bovine scavenger receptor type I in transgenic mice prevents diet-induced hyperbetalipoproteinemia.

Authors:  S Wölle; D P Via; L Chan; J A Cornicelli; C L Bisgaier
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

10.  Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice.

Authors:  M Barton; C C Haudenschild; L V d'Uscio; S Shaw; K Münter; T F Lüscher
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.